FY2025 Earnings Forecast for UNH Issued By Cantor Fitzgerald

UnitedHealth Group Incorporated (NYSE:UNH) – Investment analysts at Cantor Fitzgerald cut their FY2025 earnings per share estimates for UnitedHealth Group in a research note issued on Monday, April 21st. Cantor Fitzgerald analyst S. James now anticipates that the healthcare conglomerate will earn $26.27 per share for the year, down from their previous estimate of $29.82. Cantor Fitzgerald has a “Overweight” rating and a $700.00 price target on the stock. The consensus estimate for UnitedHealth Group’s current full-year earnings is $29.54 per share.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company had revenue of $109.58 billion for the quarter, compared to analyst estimates of $111.56 billion. During the same period last year, the company posted $6.91 EPS.

Several other research firms have also commented on UNH. Barclays cut their price target on shares of UnitedHealth Group from $642.00 to $560.00 and set an “overweight” rating on the stock in a report on Monday. Mizuho upped their price target on shares of UnitedHealth Group from $600.00 to $650.00 and gave the stock an “outperform” rating in a research report on Wednesday, April 9th. HSBC restated a “hold” rating and set a $490.00 price objective on shares of UnitedHealth Group in a research note on Tuesday. KeyCorp dropped their target price on UnitedHealth Group from $650.00 to $575.00 and set an “overweight” rating on the stock in a report on Monday. Finally, StockNews.com raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Thursday, January 23rd. Three investment analysts have rated the stock with a hold rating, nineteen have assigned a buy rating and three have assigned a strong buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Buy” and an average price target of $608.00.

UnitedHealth Group Stock Performance

Shares of NYSE:UNH opened at $427.10 on Wednesday. The firm has a market capitalization of $390.67 billion, a PE ratio of 27.55, a P/E/G ratio of 1.37 and a beta of 0.61. UnitedHealth Group has a 12 month low of $417.12 and a 12 month high of $630.73. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The business has a 50-day moving average of $508.83 and a two-hundred day moving average of $537.99.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were paid a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, March 10th. This represents a $8.40 annualized dividend and a yield of 1.97%. UnitedHealth Group’s payout ratio is 35.18%.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently modified their holdings of the business. Norges Bank bought a new position in shares of UnitedHealth Group during the fourth quarter valued at approximately $6,375,744,000. GAMMA Investing LLC grew its stake in UnitedHealth Group by 56,142.1% during the 1st quarter. GAMMA Investing LLC now owns 8,295,153 shares of the healthcare conglomerate’s stock worth $4,344,586,000 after buying an additional 8,280,404 shares during the last quarter. Raymond James Financial Inc. bought a new stake in UnitedHealth Group in the fourth quarter valued at $1,914,740,000. Amundi increased its holdings in shares of UnitedHealth Group by 97.2% in the 4th quarter. Amundi now owns 6,069,100 shares of the healthcare conglomerate’s stock worth $3,183,132,000 after acquiring an additional 2,991,470 shares during the period. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its stake in shares of UnitedHealth Group by 36.6% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 8,592,718 shares of the healthcare conglomerate’s stock valued at $4,346,712,000 after purchasing an additional 2,301,010 shares during the period. 87.86% of the stock is owned by institutional investors and hedge funds.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.